379 related articles for article (PubMed ID: 28219328)
1. β-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranes.
Donadio C; Tognotti D; Caponi L; Paolicchi A
BMC Nephrol; 2017 Feb; 18(1):68. PubMed ID: 28219328
[TBL] [Abstract][Full Text] [Related]
2. Predicting residual kidney function in hemodialysis patients using serum β-trace protein and β2-microglobulin.
Wong J; Sridharan S; Berdeprado J; Vilar E; Viljoen A; Wellsted D; Farrington K
Kidney Int; 2016 May; 89(5):1090-1098. PubMed ID: 26924065
[TBL] [Abstract][Full Text] [Related]
3. Comparison of serum concentrations of β-trace protein, β2-microglobulin, cystatin C, and creatinine in the US population.
Juraschek SP; Coresh J; Inker LA; Levey AS; Köttgen A; Foster MC; Astor BC; Eckfeldt JH; Selvin E
Clin J Am Soc Nephrol; 2013 Apr; 8(4):584-92. PubMed ID: 23335043
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
[TBL] [Abstract][Full Text] [Related]
5. Estimation of residual renal function using beta-trace protein: Impact of dialysis procedures.
Bargnoux AS; Buthiau D; Morena M; Rodriguez A; Noguera-Gonzalez ME; Gilbert O; Le Quintrec M; Kuster N; Cristol JP
Artif Organs; 2020 Jun; 44(6):647-654. PubMed ID: 31951029
[TBL] [Abstract][Full Text] [Related]
6. Estimating residual kidney function in dialysis patients without urine collection.
Shafi T; Michels WM; Levey AS; Inker LA; Dekker FW; Krediet RT; Hoekstra T; Schwartz GJ; Eckfeldt JH; Coresh J
Kidney Int; 2016 May; 89(5):1099-1110. PubMed ID: 26924062
[TBL] [Abstract][Full Text] [Related]
7. Different elimination patterns of beta-trace protein, beta2-microglobulin and cystatin C in haemodialysis, haemodiafiltration and haemofiltration.
Lindström V; Grubb A; Alquist Hegbrant M; Christensson A
Scand J Clin Lab Invest; 2008; 68(8):685-91. PubMed ID: 18609120
[TBL] [Abstract][Full Text] [Related]
8. Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in the Elderly: AGES-Kidney and MESA-Kidney.
Foster MC; Levey AS; Inker LA; Shafi T; Fan L; Gudnason V; Katz R; Mitchell GF; Okparavero A; Palsson R; Post WS; Shlipak MG
Am J Kidney Dis; 2017 Sep; 70(3):406-414. PubMed ID: 28549536
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo.
Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E
Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156
[TBL] [Abstract][Full Text] [Related]
10. Serum and urinary markers of early impairment of GFR in chronic kidney disease patients: diagnostic accuracy of urinary β-trace protein.
Donadio C
Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1407-23. PubMed ID: 20844024
[TBL] [Abstract][Full Text] [Related]
11. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
Pellicano R; Polkinghorne KR; Kerr PG
Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
[TBL] [Abstract][Full Text] [Related]
12. Effect of Membrane Permeability on Cardiovascular Risk Factors and β2m Plasma Levels in Patients on Long-Term Haemodialysis: A Randomised Crossover Trial.
Chazot C; Kirchgessner J; Pham J; Vo-Van C; Lorriaux C; Hurot JM; Zaoui E; Grassmann A; Jean G; Marcelli D
Nephron; 2015; 129(4):269-75. PubMed ID: 25825336
[TBL] [Abstract][Full Text] [Related]
13. Rebound kinetics of beta2-microglobulin after hemodialysis.
Leypoldt JK; Cheung AK; Deeter RB
Kidney Int; 1999 Oct; 56(4):1571-7. PubMed ID: 10504510
[TBL] [Abstract][Full Text] [Related]
14. Plasma Levels of Middle Molecules to Estimate Residual Kidney Function in Haemodialysis without Urine Collection.
Vilar E; Boltiador C; Wong J; Viljoen A; Machado A; Uthayakumar A; Farrington K
PLoS One; 2015; 10(12):e0143813. PubMed ID: 26629900
[TBL] [Abstract][Full Text] [Related]
15. Levels of cystatin C in low- and high-flux hemodialysis in children with end-stage renal disease.
Fadel FI; Mourad AA; Abdel Rahman AMO; Bazaraa HM; Mohamed MF; El-Lebedy DH; Soliman MM
Pediatr Nephrol; 2017 Sep; 32(9):1603-1609. PubMed ID: 28417217
[TBL] [Abstract][Full Text] [Related]
16. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
[TBL] [Abstract][Full Text] [Related]
17. β-Trace protein in hemodialysis - comparison of different therapy modalities and high flux dialyzers.
Schwab S; Bös D; Hundt F; Kleine CE; Strassburg CP; Woitas RP
Clin Chem Lab Med; 2018 Oct; 56(11):265-267. PubMed ID: 29715180
[No Abstract] [Full Text] [Related]
18. Plasma Beta-Trace Protein as a Marker of Residual Renal Function: The Effect of Different Hemodialysis Modalities and Intra-Individual Variability over Time.
van Craenenbroeck AH; Bragfors-Helin AC; Qureshi AR; Lindholm B; Sjöberg B; Anderstam B; Heimburger O; Stenvinkel P; Bárány P
Kidney Blood Press Res; 2017; 42(5):877-885. PubMed ID: 29161688
[TBL] [Abstract][Full Text] [Related]
19. Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients.
Stein G; Franke S; Mahiout A; Schneider S; Sperschneider H; Borst S; Vienken J
Nephrol Dial Transplant; 2001 May; 16(5):999-1008. PubMed ID: 11328907
[TBL] [Abstract][Full Text] [Related]
20. Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis.
Teruel-Briones JL; Fernández-Lucas M; Rivera-Gorrin M; Ruiz-Roso G; Díaz-Domínguez M; Rodríguez-Mendiola N; Quereda-Rodríguez-Navarro C
Nefrologia; 2013; 33(5):640-9. PubMed ID: 24089155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
